2024 annual financial data
Taysha Gene Therapies 2024 Operating margin
Direct answer
Operating margin was -1,097.55%.
Operating income was -91,459,000 USD and net income was -89,298,000 USD.
Operating cash flow was -81,225,000 USD.
Get free Taysha Gene Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,333,000 USD
- Operating income
- -91,459,000 USD
- Net income
- -89,298,000 USD
- Operating cash flow
- -81,225,000 USD